Eventide Asset Management, LLC
- SEC CIK
- 0001442891
- Latest filing
- Aug 14, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,327,536
- Value
- $23.8M
- % of portfolio
- 0.3%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,327,536 | $23.8M | 0.3% | −186,422−12.3% | Reduced | Holders |
| Q1 2026 | 1,513,958 | $21.0M | 0.3% | +810+0.1% | Added | Holders |
| Q4 2025 | 1,513,148 | $18.3M | 0.3% | +6480.0% | Added | Holders |
| Q3 2025 | 1,512,500 | $20.6M | 0.3% | +1,512,500 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,116,837−100.0% | Sold out | Holders |
| Q4 2023 | 1,116,837 | $16.4M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,116,837 | $20.4M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,116,837 | $24.1M | 0.4% | +658,783+143.8% | Added | Holders |
| Q1 2023 | 458,054 | $13.4M | 0.2% | +208,054+83.2% | Added | Holders |
| Q4 2022 | 250,000 | $9.24M | 0.2% | +250,000 | New | Holders |